Search results
JD Supra: Update on biosimilars in Canada – March 2024
JD Supra· 6 days agoIn this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March...
PhRMA to Revive Medicare Drug Price Lawsuit Before Fifth Circuit
Bloomberg Law· 2 days agoA health provider trade association, a patient advocacy group, and a top drug lobby will attempt to restore their case against a government drug price-setting program before a federal appeals ...
Investment Opportunities in the Drug Distribution Industry
Morningstar· 2 days agoThe market has rallied behind the US drug distribution industry recently because of the popularity of GLP-1s, easing generic drug deflation, and an increase in specialty asset investments. Drug ...
AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
GuruFocus.com via Yahoo Finance· 5 days agoJust wondering if you could maybe frame a little bit for us the opportunity for Skyrizi in UC versus Crohn's disease. I think last time, we heard from J&J, Crohn's represented about $7 billion ...